Showing results (151-160 of 390) with videos related to

Sort By:
Pageof 39
Human Vaccines & Immunotherapeutics|March 31, 2022
Explorative study regarding influenza vaccine hesitancy among HIV-infected patientsValentina Marchese, Samuele Storti, Claudia Morganti, et al.
Frontiers in Cellular and Infection Microbiology|May 1, 2023
Case report: An occult hepatitis B virus infection reactivation in an HIV/HCV coinfected patient during an immune reconstitution inflammatory syndromeSerena Zaltron, Anna Cambianica, Marco Di Gregorio, et al.
Current Drug Targets|May 9, 2013
Differential scanning calorimetry as a tool to investigate the transfer of anticancer drugs to biomembrane modelMaria Grazia Sarpietro, Maria Lorena Accolla, Christian Celia, et al.
Cytokine|May 1, 2021
Descriptive modification of inflammatory markers in HIV patients after cART initiation according to gender, smoking habit, CMV infection, BMI and serum lipidsIsabella Zanella, Giorgio Biasiotto, Francesco Castelli, et al.
Molecules (Basel, Switzerland)|September 23, 2022
Benzo[k,l]xanthene Lignan-Loaded Solid Lipid Nanoparticles for Topical Application: A Preliminary StudyCristina Torrisi, Nunzio Cardullo, Stefano Russo, et al.
Journal of Clinical Medicine|November 9, 2024
Effect of Oral Bisphosphonates on Vertebral Fractures in Males Living with HIV: A Seven Year StudyLetizia Chiara Pezzaioli, Teresa Porcelli, Andrea Delbarba, et al.
Respiratory Care|December 13, 2018
A COPD Case-Finding Program in a Large Cohort of HIV-Infected PersonsEugenia Quiros-Roldan, Maria Chiara Pezzoli, Marialma Berlendis, et al.
The American Journal of Tropical Medicine and Hygiene|August 5, 2010
Combined intravenous treatment with artesunate and quinine for severe malaria in ItalyAlessandro Bartoloni, Lina Tomasoni, Filippo Bartalesi, et al.
Antibiotics (Basel, Switzerland)|December 30, 2025
Cefiderocol as a Successful Therapy for Osteomyelitis Due to XDR Pseudomonas aeruginosa: A Case Report and Literature ReviewAlice Mulè, Anna Cambianica, Alberto Matteelli, et al.
The New Microbiologica|March 6, 2015
Clinical course of chronic hepatitis B patients receiving nucleos(t)ide analogues after virological breakthrough during monotherapy with lamivudineMaria Antonia De Francesco, Franco Gargiulo, Angiola Spinetti, et al.
Pageof 39